Clinical Trials Browser

Phase 1 × dalpiciclib × Gastrointestinal × Clear all

NCT06225921 2024-03-06

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Phase 1 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma